An unexpected, and novel, target for prostate cancer—our biological clock

Hiroshima plans Japan’s first mass virus tests
15 January 2021
Trust is ordered to pay {pound}7500 to man who was not “best fit” for role with young women
15 January 2021

An unexpected, and novel, target for prostate cancer—our biological clock

Our biological or circadian clock synchronizes all our bodily processes to the natural rhythms of light and dark. It’s no wonder then that disrupting the clock can wreak havoc on our body. In fact, studies have shown that when circadian rhythms are disturbed through sleep deprivation, jet lag, or shift work, there is an increased incidence of some cancers including prostate cancer, which is the second leading cause of cancer death for men in the U.S. With an urgent need to develop novel therapeutic targets for prostate cancer, researchers at the Sidney Kimmel Cancer—Jefferson Health (SKCC) explored the circadian clock and found an unexpected role for the clock gene CRY-1 in cancer progression. The study was published on January 15th in Nature Communications.

Comments are closed.